Price (delayed)
$0.9094
Market cap
$76.81M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.98
Enterprise value
-$8.88M
Sutro Biopharma, Inc., located in South San Francisco, is a clinical-stage drug discovery, development and manufacturing company. Using precise protein engineering and rational design, Sutro is advancing next-generation oncology therapeutics.
There are no recent dividends present for STRO.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.